Compare CADL & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | FTK |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 754.7M | 720.7M |
| IPO Year | 2021 | 1997 |
| Metric | CADL | FTK |
|---|---|---|
| Price | $9.83 | $22.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $19.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 2.1M | 292.5K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.62 | ★ 147.06 |
| EPS | N/A | ★ 0.12 |
| Revenue | $125,000.00 | ★ $136,092,000.00 |
| Revenue This Year | N/A | $13.33 |
| Revenue Next Year | N/A | $16.38 |
| P/E Ratio | ★ N/A | $184.92 |
| Revenue Growth | N/A | ★ 214.53 |
| 52 Week Low | $4.35 | $10.96 |
| 52 Week High | $11.36 | $25.54 |
| Indicator | CADL | FTK |
|---|---|---|
| Relative Strength Index (RSI) | 63.22 | 49.57 |
| Support Level | $4.89 | $15.01 |
| Resistance Level | N/A | $22.24 |
| Average True Range (ATR) | 0.64 | 1.39 |
| MACD | 0.09 | -0.26 |
| Stochastic Oscillator | 55.40 | 24.38 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.